311 results on '"Doranz, Benjamin J."'
Search Results
2. Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
3. Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
4. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
5. Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point
6. Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
7. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
8. Testing for Off-target Binding
9. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
10. Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
11. Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics
12. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
13. An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
14. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
15. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
16. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
17. A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants.
18. Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses
19. Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles
20. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
21. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein
22. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region
23. Mxra8 is a receptor for multiple arthritogenic alphaviruses
24. Abstract 2646: Screening the membrane proteome to determine antibody specificity and de-risk CAR-T cell development
25. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices
26. Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity
27. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
28. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice
29. HCV E2 core structures and mAbs: something is still missing
30. Abstract 317: Isolation of highly selective antibodies against claudin 18.2 for the treatment of solid tumors
31. Abstract 318: Atomic-level specificity of Claudin 6 monoclonal antibodies isolated for treating solid tumors
32. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function
33. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening
34. Systematic analysis of human antibody response to ebolavirus glycoprotein reveals high prevalence of neutralizing public clonotypes
35. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
36. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection
37. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
38. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
39. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress
40. Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope
41. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
42. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
43. Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
44. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
45. Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
46. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies
47. Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
48. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
49. Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
50. A novel antigenic site spanning domains I and III of the Zika virus envelope glycoprotein is the target of strongly neutralizing human monoclonal antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.